Indication
Progressive vaccinia
Progressive vaccinia, historically termed vaccinia necrosum or vaccinia gangrenosum, is a rare, severe, and potentially fatal complication of smallpox vaccination using live vaccinia virus. Read more about Progressive vaccinia
1 drugs 1 manufacturers
Drugs that treat it
Common Progressive vaccinia therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProgressive vaccinia, historically termed vaccinia necrosum or vaccinia gangrenosum, is a rare, severe, and potentially fatal complication of smallpox vaccination using live vaccinia virus.
It develops almost exclusively in individuals with severe cell-mediated immunodeficiencies, such as congenital T-cell defects, advanced HIV infection, hematologic malignancies, or profound immunosuppressive therapy.
Pathophysiologically, the host’s inability to mount an effective immune response allows uninhibited viral replication, characterized by an expanding, non-healing, painless ulceration and progressive tissue necrosis at the inoculation site.
Without prompt intervention, the viral infection relentlessly spreads to adjacent cutaneous tissue and disseminates via viremia to distant skin sites, mucous membranes, and visceral organs.
- cdc.gov
Progressive vaccinia, historically termed vaccinia necrosum or vaccinia gangrenosum, is a rare, severe, and potentially fatal complication of smallpox vaccination using live vaccinia virus
- nih.gov
Progressive vaccinia, historically termed vaccinia necrosum or vaccinia gangrenosum, is a rare, severe, and potentially fatal complication of smallpox vaccination using live vaccinia virus It develops almost exclusively in individuals with severe cell-mediated immunodeficiencies, such as congenital T-cell defects, advanced HIV infection, hematologic malignancies, or profound immunosuppressive therapy Pathophysiologically, the host’s inability to mount an effective immune response allows uninhibi...
- nih.gov
It develops almost exclusively in individuals with severe cell-mediated immunodeficiencies, such as congenital T-cell defects, advanced HIV infection, hematologic malignancies, or profound immunosuppressive therapy Without prompt intervention, the viral infection relentlessly spreads to adjacent cutaneous tissue and disseminates via viremia to distant skin sites, mucous membranes, and visceral organs
- azdhs.gov
Pathophysiologically, the host’s inability to mount an effective immune response allows uninhibited viral replication, characterized by an expanding, non-healing, painless ulceration and progressive tissue necrosis at the inoculation site Without prompt intervention, the viral infection relentlessly spreads to adjacent cutaneous tissue and disseminates via viremia to distant skin sites, mucous membranes, and visceral organs
- vdict.com
Pathophysiologically, the host’s inability to mount an effective immune response allows uninhibited viral replication, characterized by an expanding, non-healing, painless ulceration and progressive tissue necrosis at the inoculation site
Personalize your experience
Follow Progressive vaccinia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.